Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
179.00    0.00 (0.00%)
Bid:
179.00
Ask:
184.00
Spread: 5.00 (2.793%)
Market Cap: £34.79m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

Director Dealing

20 Oct 2022 12:03

RNS Number : 5781D
Palace Capital PLC
20 October 2022
Β 

20 October 2022

Β 

Β 

Palace Capital PLC

("Palace Capital", the "Company" or the "Group")

Β 

Director Dealing

Β 

Palace Capital announces that Matthew Simpson, Chief Financial Officer, today purchased 8,471 ordinary shares of 10p each at 236.094p per share.

Β 

For further information, contact:

PALACE CAPITAL PLC

Steven Owen, Interim Executive Chairman / Matthew Simpson, Chief Financial OfficerTel. +44 (0)20 3301 8330

Β 

Financial PRΒ 

FTI Consulting

Dido Laurimore/ Giles Barrie

Tel: +44 (0)20 3727 1000

palacecapital@fticonsulting.com

Β 

About Palace Capital plc (www.palacecapitalplc.com)

Β 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Matthew Simpson (Chief Financial Officer)

2

Reason for the notification

a)

Position/status

See 1 a) above

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Palace Capital plc

b)

LEI

2138009JDFQOXJFCJQ05

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Β Identification code

Ordinary shares of 10 pence each

Β 

Identification code (ISIN) for Palace Capital plc ordinary shares: GB00BF5SGF06

b)

Nature of the transaction

Acquisition of ordinary shares

c)

Price(s) and volume(s)

Β 8,471 ordinary shares at 236.094 pence per share

d)

Aggregated information

- Aggregated volume

- Price

Β 

8,471

236.094p

e)

Date of the transaction

20 October 2022

f)

Place of the transaction

London Stock Exchange

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHFLFEIIALIFIF
Date   Source Headline
14th Jun 20227:01 amRNSResults for the year ended 31 March 2022
14th Jun 20227:00 amRNSBoard Change
1st Jun 20225:04 pmRNSTotal Voting Rights
6th Apr 20227:00 amRNSTrading update and dividend increase
25th Mar 20229:10 amRNSHolding(s) in Company
16th Mar 20223:58 pmRNSHolding(s) in Company
15th Mar 20222:03 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSDividend Declaration and Market Update
14th Mar 20229:46 amRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPalace Capital exceeds disposal strategy targets
20th Jan 20224:40 pmRNSSecond Price Monitoring Extn
20th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Jan 20227:00 amRNSAcquisition of Maidenhead office building
20th Dec 20217:00 amRNSDisposal strategy nears completion
16th Dec 20217:00 amRNSAppointment of new Chairman
15th Dec 202110:46 amEQSHardman & Co Research: Hardman & Co Video | Analyst interview Q&A with Mike Foster on Palace Capital (PCA) | Interim results - ammunition for major dividend rises
9th Dec 20217:00 amRNSLetting of office space at Hudson Quarter, York
6th Dec 20217:00 amRNSSale of Staines Office Building
3rd Dec 202112:40 pmEQSHardman & Co Research : Palace Capital (PCA) - Interim results: ammunition for major dividend rises
29th Nov 20217:00 amRNSDisposal strategy continues with Aldershot sale
18th Nov 20217:00 amRNSDirector Dealing
17th Nov 20211:04 pmRNSINVESTOR PRESENTATION
16th Nov 20217:00 amRNSInterim Results
12th Nov 202110:30 amRNSHolding(s) in Company
12th Nov 20217:00 amRNSAppointment of Matthew Simpson as CFO
26th Oct 20217:00 amRNSUpdate on Chair recruitment
19th Oct 20217:00 amRNSTrading Update
4th Oct 20214:35 pmRNSPrice Monitoring Extension
30th Sep 20214:41 pmRNSSecond Price Monitoring Extn
30th Sep 20214:36 pmRNSPrice Monitoring Extension
30th Sep 20217:00 amRNSHolding(s) in Company
30th Sep 20217:00 amRNSDisposal of Holding in Circle Property Plc
20th Aug 20214:10 pmRNSDirector Dealing
13th Aug 20211:00 pmRNSDirectorate Change
29th Jul 20214:30 pmRNSResult of AGM
27th Jul 20217:00 amRNSChairman retirement & strategy update
19th Jul 20217:00 amRNSDisposal programme continues with Weybridge sale
14th Jul 20217:00 amRNSTotal Voting Rights
25th Jun 20219:00 amEQSHardman & Co Research : Hardman Talks Video | Palace Capital Management Presentation
23rd Jun 20211:45 pmRNSAnnual Report and Notice of Annual General Meeting
21st Jun 202111:30 amEQSHardman & Co Research: Palace Capital (PCA): Dividend recovery ahead of expectations
16th Jun 202110:52 amRNSDirector Dealing
9th Jun 20214:10 pmEQSHardman & Co Research : Hardman Talks Video Event | Palace Capital Management Presentation
8th Jun 20217:00 amRNSFinal Results for the year ended 31 March 2021
1st Jun 20214:03 pmRNSNotice of Results & Investor Presentation
14th May 20215:18 pmRNSDirector Declaration
22nd Apr 20214:40 pmEQSHardman & Co Research: Palace Capital (PCA): Strong trading update
14th Apr 20217:00 amRNSTrading update
19th Mar 20215:48 pmRNSDirector/PDMR Shareholding
10th Mar 20219:05 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.